Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human glutamate oxaloacetate transaminase 1

EU orphan designation number: EU/3/15/1443   
Active ingredient: Recombinant human glutamate oxaloacetate transaminase 1
Indication: Treatment of glioma
Sponsor: Dr. Regenold GmbH
Zöllinplatz 4, 79410 Badenweiler, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/02/2015 Orphan designation EMA/OD/251/14 (2015)941 of 12/02/2015
20/10/2015 Transfer of orphan designation EMA/OD/251/14/T/01 (2015)7311 of 16/10/2015
07/07/2017 Change of name and/or address of sponsor